An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
Article in Pain Medicine (March 2019)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Pain Medicine (March 2019)